Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 7 open-market purchases and 8 sales; 168 institutions reported holding it in 13F filings for Q3 2026, worth $1.69B in total; no superinvestor holds it.
Politicians who traded RAPP
No member of Congress has reported a trade in Rapport Therapeutics, Inc. shares or options since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.